Rethinking on the concept of biomarkers in preclinical Alzheimer's disease

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Valentina BertiAlberto Pupi

Abstract

The neuropathological processes eventually leading to Alzheimer's disease (AD) are thought to start decades before the appearance of clinical symptoms and the clinical diagnosis of AD dementia. The term "preclinical AD" has been recently introduced to identify this "silent stage" of AD, when the disease is already present, but symptoms are not yet clinically evident. Advances in AD biomarkers have dramatically improved the ability to detect AD pathological processes in vivo in cognitively intact subjects, thus demonstrating the presence of AD pathology in the preclinical phase. This review focuses on the recent advances in the field of neuroimaging and CSF AD biomarkers specifically in the preclinical phase of AD, and aims to discuss the significance that such biomarkers could have in cognitively intact subjects. Even though the use of such biomarkers in AD preclinical phase has contributed to improve our understanding of AD early pathological processes, it raised also a number of new challenges that still remain to be overcome, such as a better definition of the clinical and individual significance of currently known biomarkers in preclinical stages and the development of novel biomarkers of different early AD-related events.

References

Jul 1, 1997·Neurobiology of Aging·W SilvermanJ Wegiel
Mar 11, 1999·Annals of Neurology·J L Price, J C Morris
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kooresh Shoghi-JadidJorge R Barrio
Mar 3, 2004·Annals of Neurology·William E KlunkBengt Långström
Jul 13, 2004·Annals of the New York Academy of Sciences·Hyoung-Gon LeeMark A Smith
Mar 5, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Lisa Mosconi
Mar 22, 2005·The International Journal of Biochemistry & Cell Biology·Jillian R Gee, Jeffrey N Keller
May 25, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Alberto PupiSandro Sorbi
Oct 3, 2006·Brain : a Journal of Neurology·Katharina BuergerHarald Hampel
Jan 16, 2007·Neurobiology of Aging·Lisa MosconiMony J de Leon
Nov 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lisa MosconiMony J de Leon
Dec 12, 2007·Archives of Neurology·Estrella Gómez-TortosaAdriano Jiménez-Escrig
Nov 13, 2008·Archives of Neurology·Howard Jay AizensteinWilliam E Klunk
Jan 15, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Lisa MosconiMony J de Leon
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Eric M ReimanRichard J Caselli
Apr 18, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michel KooleKoen Van Laere
May 27, 2009·Neuropsychologia·Yaakov Stern
Jun 16, 2009·Neurochemistry International·Karen KoopmanSebastiaan Engelborghs
Jul 23, 2009·JAMA : the Journal of the American Medical Association·Niklas MattssonKaj Blennow
Aug 4, 2009·International Journal of Geriatric Psychiatry·Kajsa SämgårdElisabet Londos
Aug 12, 2009·Current Neurology and Neuroscience Reports·David A Wolk, William Klunk
Aug 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nelleke TolboomBart N M van Berckel
Oct 23, 2009·Journal of Medicinal Chemistry·Hank F KungDaniel Skovronsky
Dec 17, 2009·Archives of Neurology·Victor L VillemagneChristopher C Rowe
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lisa MosconiMony J de Leon
May 11, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·William J JagustUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 18, 2010·Neurobiology of Aging·Christopher C RoweVictor L Villemagne
Oct 12, 2010·Lancet Neurology·Bruno DuboisPhilip Scheltens
Oct 20, 2010·Neuron·Lars BertramRudolph E Tanzi
Nov 6, 2010·Nature Medicine·Kaj Blennow
Nov 12, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sanjay W PimplikarLi-Huei Tsai
Dec 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Karl Herrup
Dec 25, 2010·Annals of Neurology·Jonathan M SchottUNKNOWN Alzheimer's Disease Neuroimaging Initiative Investigators
Feb 12, 2011·Brain : a Journal of Neurology·Gaël ChételatUNKNOWN Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group
Jun 1, 2011·Seminars in Nuclear Medicine·Shankar Vallabhajosula
Oct 11, 2011·Trends in Cognitive Sciences·William J Jagust, Elizabeth C Mormino
Dec 23, 2011·Neurology·Bradford C DickersonUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Citations

Apr 7, 2017·Annals of Clinical and Translational Neurology·Urmi SenguptaRakez Kayed
Dec 8, 2016·Behavioural Pharmacology·Alfredo Meneses
May 16, 2017·Molecular & Cellular Proteomics : MCP·Johan BjörkestenUlf Landegren
Oct 27, 2017·F1000Research·Leonardo IaccarinoDaniela Perani
Apr 14, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gemma LombardiSandro Sorbi
Nov 13, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Minoru KouzukiKatsuya Urakami
Mar 12, 2019·Scientific Reports·Benjamin GoudeyUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 10, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Seyedeh Nazanin HajjariBehzad Baradaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

Science of Aging Knowledge Environment : SAGE KE
Clinton B WrightLawrence S Honig
Clinical Chemistry and Laboratory Medicine : CCLM
David Prvulovic, H Hampel
© 2022 Meta ULC. All rights reserved